Difference between revisions of "Mixed germ cell tumour"

From Libre Pathology
Jump to navigation Jump to search
Line 13: Line 13:
| IF        =
| IF        =
| Gross      =
| Gross      =
| Grossing  =
| Grossing  = [[orchiectomy]]
| Site      = [[ovary]], [[testis]], [[mediastinum]], other
| Site      = [[ovary]], [[testis]], [[mediastinum]], other
| Assdx      =
| Assdx      =

Revision as of 00:38, 14 August 2014

Mixed germ cell tumour
Diagnosis in short

Mixed germ cell tumour. H&E stain.

LM depends on the components
LM DDx other germ cell tumours
IHC variable
Grossing notes orchiectomy
Site ovary, testis, mediastinum, other

Signs mass lesion
Prevalence most common germ cell tumour
Blood work +/-AFP elevated, +/-beta-hCG elevated, +/-LDH elevated
Prognosis worse than seminoma/dysgerminoma
Clin. DDx gonads: germ cell tumours, other tumours

Mixed germ cell tumour, abbreviated MGCT, is a lesion composed of different germ cell tumours. Most germ cell tumours are mixed.

General

  • 60% of GCTs are mixed. †

Common combinations:

  1. Teratoma + embryonal carcinoma + endodermal sinus tumour (yolk sac tumour) (TEE).
  2. Seminoma + embryonal (SE).
  3. Teratoma + embryonal +(TE).

Memory device: TEE + all combinations have embryonal carcinoma.

Note:

  • † Numbers vary between sources. One series suggests it is almost 70%.[1]
  • There has been in increase in MGCTs over the past 20 years that is probably due to changes how in how GCTs are classified.[2]

Microscopic

Features:

  • Depends on components.

Notes:

  • If one cannot identify the component... it is probably yolk sac as this has so many different patterns.

Images

www:

IHC

  • Beta-hCG +ve - if syncytiotrophoblasts are present.
  • AFP +ve - a yolk sac tumour component is present.
  • GFAP +ve - if neuroepithelium is present.

A panel:

  • PLAP.
  • CD30 +ve -- embryonal carcinoma.
  • CD117 +ve -- seminoma.
  • D2-40 +ve -- seminoma, useful for LVI.
  • Pankeratin +ve -- embryonal carcinoma.
  • CEA-M.
  • EMA +ve -- metastatic carcinoma.[3]
  • Vimentin.
  • AFP +ve -- yolk sac tumour.
  • A1A +ve -- yolk sac tumour.

Sign out

TESTIS, RIGHT, ORCHIECTOMY:
- MIXED GERM CELL TUMOUR, pT1 pNx:
-- 80% OF TUMOUR TERATOMA.
-- 20% OF TUMOUR SEMINOMA.
-- PLEASE SEE TUMOUR SUMMARY.

See also

References

  1. Mosharafa, AA.; Foster, RS.; Leibovich, BC.; Ulbright, TM.; Bihrle, R.; Einhorn, LH.; Donohue, JP. (Apr 2004). "Histology in mixed germ cell tumors. Is there a favorite pairing?". J Urol 171 (4): 1471-3. doi:10.1097/01.ju.0000116841.30826.85. PMID 15017200.
  2. Trabert, B.; Stang, A.; Cook, MB.; Rusner, C.; McGlynn, KA. (Aug 2011). "Impact of classification of mixed germ-cell tumours on incidence trends of non-seminoma.". Int J Androl 34 (4 Pt 2): e274-7. doi:10.1111/j.1365-2605.2011.01187.x. PMID 21623833.
  3. Shek, TW.; Yuen, ST.; Luk, IS.; Wong, MP. (Mar 1996). "Germ cell tumour as a diagnostic pitfall of metastatic carcinoma.". J Clin Pathol 49 (3): 223-5. PMID 8675733.